WASHINGTON — The Pharmaceutical Care Management Association (PCMA) announced that Waltz Health is joining the trade association as its newest member.
“PCMA is proud to represent pharmacy benefit companies and the addition of Waltz Health to our membership is testament to the diversification of business models the PBM industry can offer employers and health plans across the country,” said PCMA President and CEO JC Scott. “While PBMs continue to innovate and evolve pharmacy benefit offerings and options, the one constant for all PCMA members remains a commitment to increasing access and affordability for prescription drugs for all patients.”
Founded in 2021 and headquartered in Chicago, Waltz Health integrates its technology into the pharmacy benefit process to deliver value to its clients and members. Powered by artificial intelligence (AI), Waltz Health has delivered a Marketplace Search application that saves people more money on their drugs while also filling gaps in prescription fill data for health plans and plan sponsors. Members automatically receive the lowest price at the pharmacy counter through either their benefits or a cash-pay option with a discount. Later this year, Waltz Health will deliver its next solution focused on improving access and affordability for high-cost medications. Waltz Health currently serves millions of people across the country with its proprietary technology solutions.
“Our mission is to work with all of the players within the prescription drug supply chain to realign the incentives to bring down drug costs for all healthcare consumers, and PBMs are an incredibly important partner in that mission,” said Waltz Health Co-founder and CEO Mark Thierer. “PCMA is a respected organization that we’re very proud to partner with, so we look forward to working with its team.”
PCMA continues to lead the effort in promoting PBMs and the proven tools they utilize, which are recognized by consumers, employers, policymakers, and others as key drivers in lowering prescription drug costs and increasing access. As of March 2023, there are 73 full-service pharmacy benefit companies representing more than 266 million patients with health insurance.